Chaime Orlev

Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA.

Huntleigh USA Corp. provides security solutions for individuals and businesses. The firm offers active site monitoring, advanced technology solutions, video surveillance-as-a service, professional security and aviation & related services. It provides limited security services, such as charter flight and cargo screening, for airlines, as well as skycap, agent and special service personnel. The company was founded in 1992 and is headquartered in Irving, TX.

Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel.

Solel Solar Systems Ltd. provides solar thermal power services. It designs, manufactures and installs turnkey solar fields for large scale power generation. It offers technology for new solar power plants in the US, Spain and other sun-rich locations. Solel's technology converts sunshine into useful thermal energy, and subsequently into electricity, by way of parabolic mirrors that concentrate the solar energy onto solar thermal receivers containing a heat transfer fluid. It was founded in 1992 and is headquartered in Beit Shemesh, IL.

Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel.